Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure

Toxicology and Applied Pharmacology

Volumn 241, Issue 3, 2009, Pages 253-259

  Burchiel, Scott W ^a   Mitchell, Leah A ^a   Lauer, Fredine T ^a   Sun, Xi ^a   McDonald, Jacob D ^b   Hudson, Laurie G ^a   Liu, Ke Jian ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Antibody suppression; Arsenic; Arsenic trioxide; Biodistribution; Immunotoxicity; Inhalation; Mice

Indexed keywords

ARSENIC TRIOXIDE; CONCANAVALIN A; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BIOACCUMULATION; BLADDER; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOTOXICITY; INHALATION; KIDNEY; LIVER; LUNG; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MITOGENESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; SPLEEN; T LYMPHOCYTE; TISSUE DISTRIBUTION;

AEROSOLS; ANIMALS; ANTIBODY FORMATION; ARSENIC; ARSENICALS; HEMOLYTIC PLAQUE TECHNIQUE; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; INDICATORS AND REAGENTS; INHALATION EXPOSURE; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; MITOGENS; MITOSIS; OXIDES; RECEPTORS, CELL SURFACE; SPLEEN; TISSUE DISTRIBUTION;

MUS; OVIS ARIES;

EID: 70350580640     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.09.019     Document Type: Article

References (39)

1. Apostoli P., Bartoli D., Alessio L., and Buchet J.P. Biological monitoring of occupational exposure to inorganic arsenic. Occup. Environ. Med. 56 (1999) 825-832
2. ATSDR. Arsenic Toxicologic Profile (2007) August
3. Aranyi C., Bradof J.N., O'Shea W.J., Graham J.A., and Miller F.J. Effects of arsenic trioxide inhalation exposure on pulmonary antibacterial defenses in mice. J. Toxicol. Environ. Health 15 (1985) 163-172
4. Bide R.W., Armour S.J., and Yee E. Allometric respiration/body mass data for animals to be used for estimates of inhalation toxicity to young adult humans. J. Applied. Toxicol. 20 (2000) 273-290
5. Binder S., Forney D., Kaye W., and Paschal D. Arsenic exposure in children living near a former copper smelter. Bull. Environ. Contam. Toxicol. 39 (1987) 114-121
6. Bobé P., Bonardelle D., Benihoud K., Opolon P., and Chelbi-Alix M.K. Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 108 (2006) 3967-3975
7. Burns L.A., and Munson A.E. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55). J. Pharmacol. Exp. Ther. 265 (1993) 178-186
8. Burns L.A., Sikorski E.E., Saady J.J., and Munson A.E. Evidence for arsenic as the immunosuppressive component of gallium arsenide. Toxicol. Appl. Pharmacol. 110 (1991) 157-169
9. Carter D.E., Aposhian H.V., and Gandolfi A.J. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol. Appl. Pharmacol. 193 (2003) 309-334
10. Cohen S.M., Arnold L.L., Eldan M., Lewis A.S., and Beck B.D. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 36 (2006) 99-133
11. Gao J., Mitchell L.A., Lauer F.T., and Burchiel S.W. p53 and ATM/ATR regulate 7,12-dimethylbenz[a]anthracene-induced immunosuppression. Mol. Pharmacol. 73 (2008) 137-146
12. Gentry P.R., Covington T.R., Mann S., Shipp A.M., Yager J.W., and Clewell III H.J. Physiologically based pharmacokinetic modeling of arsenic in the mouse. J. Toxicol. Environ. Health A 67 (2004) 43-71
13. Guyton A.C. Measurement of the respiratory volumes of laboratory animals. American Journal of Physiology 150 (1974) 70-77
14. Hysong T.A., Burgess J.L., Cebrián Garcia M.E., and O'Rourke M.K. House dust and inorganic urinary arsenic in two Arizona mining towns. J. Expo. Anal. Environ. Epidemiol. 13 (2003) 211-218
15. Kantarjian H., O'Brien S., Cortes J., Wierda W., Faderl S., Garcia-Manero G., Issa J.P., Estey E., Keating M., and Freireich E.J. Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years. Cancer 113 (2008) 1933-1952
16. Lemarie A., Morzadec C., Bourdonnay E., Fardel O., and Vernhet L. Human macrophages constitute targets for immunotoxic inorganic arsenic. J. Immunol. 177 (2006) 3019-3027
17. Luster M.I., Portier C., Pait D.G., White Jr. K.L., Gennings C., Munson A.E., and Rosenthal G.J. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18 (1992) 200-210
18. Milham S., and Strong T. Human arsenic exposure in relation to a copper smelter. Environ. Res. 7 (1974) 176-182
19. Mitchell L.A., Lauer F.T., Burchiel S.W., and McDonald J.D. Mechanisms of inhaled multiwalled carbon nanotube-induced systemic immune suppression in mice. Nature Nanotechnol. 4 (2009) 451-456
20. Morales A.A., Gutman D., Cejas P.J., Lee K.P., and Boise L.H. Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis. J. Biol. Chem. 284 (2009) 12886-12895
21. Morse D.L., Harrington J.M., Housworth J., Landrigan P.J., and Kelter A. Arsenic exposure in multiple environmental media in children near a smelter. Clin. Toxicol. 14 (1979) 389-399
22. National Research Council Report (NRC). Arsenic in drinking water (1999), National Academy Press, Washington, DC
23. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., and Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163 (2000) 203-297
24. Pi J., Yamauchi H., Kumagai Y., Sun G., Yoshida T., Aikawa H., Hopenhayn-Rich C., and Shimojo N. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environmental Health Perspectives 110 (2002) 331-336
25. Radabaugh T.R., and Aposhian H.V. Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol. 13 (2000) 26-30
26. Radabaugh T.R., Sampayo-Reyes A., Zakharyan R.A., and Aposhian H.V. Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15 (2002) 692-698
27. Romero D.L., Mounho B.J., Lauer F.T., Born J.L., and Burchiel S.W. Depletion of glutathione by benzo(a)pyrene metabolites, ionomycin, thapsigargin, and phorbol myristate in human peripheral blood mononuclear cells. Toxicol. Appl. Pharmacol. 144 (1997) 62-69
28. Shi H., Hudson L.G., and Liu K.J. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. Free. Radic. Biol. Med. 37 (2004) 5582-5593
29. Sikorski E.E., Burns L.A., Stern M.L., Luster M.I., and Munson A.E. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response. Toxicol. Appl. Pharmacol. 110 (1991) 129-142
30. Sikorski E.E., Burns L.A., McCoy K.L., Stern M., and Munson A.E. Suppression of splenic accessory cell function in mice exposed to gallium arsenide. Toxicol. Appl. Pharmacol. 110 (1991) 143-156
31. Sikorski E.E., McCay J.A., White Jr. K.L., Bradley S.G., and Munson A.E. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam. Appl. Toxicol. 13 (1989) 843-858
32. Smith T.J., Crecelius E.A., and Reading J.C. Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ. Health Perspect. 19 (1977) 89-93
33. Soto-Peña G.A., Luna A.L., Acosta-Saavedra L., Conde P., López-Carrillo L., Cebrián M.E., Bastida M., Calderón-Aranda E.S., and Vega L. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J. 20 (2006) 779-781
34. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., and Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74 (2000) 289-299
35. Thomas D.J., Styblo M., and Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176 (2001) 127-144
36. U.S. Environmental Protection Agency. Environmental Monitoring Systems Laboratory, Office of Research and Development. Determination of trace elements in waters and wastes of inductively coupled plasma - mass spectrometry. Rev 5.4 (1994) Method 220.8, pp 9-10.
37. Waalkes M.P., and Liu J. Purine nucleoside phosphorylase: a fortuitous cytosolic arsenate reductase?. Toxicol. Sci. 70 (2002) 1-3
38. Wang L., Zhou G.B., Liu P., Song J.H., Liang Y., Yan X.J., Xu F., Wang B.S., Mao J.H., Shen Z.X., Chen S.J., and Chen Z. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 4826-4831
39. Webb D.R., Wilson S.E., and Carter D.E. Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide, or arsenic(III) oxide intratracheally instilled into rats. Toxicol. Appl. Pharmacol. 82 (1986) 405-416